Oncology Clinical Trial

This trial is for cancer patients currently receiving carboplatin, a chemotherapy drug used for various cancer types.

This companion study can be undertaken alongside your regular treatment without changes to your doctor's plan. The trial focuses on improving the precision of carboplatin dosing to prevent side effects and undertreatment. It investigates whether real-time kidney function measurement on the day of carboplatin administration can enhance dosage accuracy.

In this trial, participants will receive an Iohexol injection to accurately assess kidney function before their carboplatin infusion.